Incorporation of n-3 polyunsaturated fatty acids into phospholipids of a marine bacterium Vibrio sp. cultivated with sardine oil

1992 ◽  
Vol 73 (2) ◽  
pp. 169-171 ◽  
Author(s):  
Seiichi Ando ◽  
Kazuya Nakajima ◽  
Mutsuo Hatano
2013 ◽  
Vol 2 (6) ◽  
pp. 97 ◽  
Author(s):  
Juan Antonio Noriega-Rodriguez ◽  
Esther Carrillo-Perez ◽  
Nohemi Gamez-Meza ◽  
Luis A. Medina-Juarez ◽  
Ramiro Baeza-Jimenez ◽  
...  

<p>In the present work, direct enzyme-catalyzed esterification of n-3 polyunsaturated fatty acids (n-3 PUFA) isolated from sardine oil was optimized to obtain structured acyglycerols. A n-3 PUFA concentrate was prepared by urea crystallization of refined sardine oil and esterification was carried out mixing free fatty acids and glycerol at different molar ratios (<em>M</em> = 0.48, 1.5, 3.0, 4.5 and 5.52 mol/mol), using an immobilized lipase preparation from <em>Candida antarctica</em> (NV-435) at different temperatures (<em>T</em> = 38, 45, 55, 65 and 72 °C) and reaction times (<em>t</em> = 0.7, 2.75, 5.75, 8.75 and 10.8 h) in a rotatable central composition design. The degree of esterification was determined by analysis of the acylglycerides produced, using liquid chromatography (HPLC-ELSD). Optimization by response surface methodology (RSM) showed that in order to obtain higher esterification levels of n-3 PUFA to glycerol (99.5%), a molar ratio of 1.3 mol n-3 PUFA/mol glycerol, time 8.3 h and temperature 38 °C, are required. However, results of this work show that it is possible to drive the reaction to any determined product (MAG, DAG or TAG) by modifying the reaction conditions.</p>


Author(s):  
Charanyaa Sampath ◽  
N. Anita ◽  
B. D. Prasanna ◽  
Iyyaswami Regupathi

1998 ◽  
Vol 75 (6) ◽  
pp. 733-736 ◽  
Author(s):  
Angélica Ganga ◽  
Susana Nieto ◽  
Julio Sanhuez ◽  
Claudio Romo ◽  
Hernán Speisky ◽  
...  

2020 ◽  
Vol 132 ◽  
pp. 109091
Author(s):  
Vanessa Sales de Oliveira ◽  
Davy Willian Hidalgo Cháves ◽  
Ormindo Domingues Gamallo ◽  
Alexandra Christine Helena Frankland Sawaya ◽  
Geni Rodrigues Sampaio ◽  
...  

2006 ◽  
Vol 50 (2) ◽  
pp. 358-360 ◽  
Author(s):  
HIRAMITSU SUZUKI ◽  
SHUN WADA ◽  
SEIICHI HAYAKAWA ◽  
SINPATIRO TAMURA

2018 ◽  
Vol 240 ◽  
pp. 286-294 ◽  
Author(s):  
R. Morales-Medina ◽  
M. Munio ◽  
A. Guadix ◽  
E.M. Guadix ◽  
F. Camacho

2020 ◽  
Vol 36 (2) ◽  
pp. 95-106
Author(s):  
Agnieszka M. Piróg-Balcerzak ◽  
Anna K. Bażyńska ◽  
Katarzyna Biernacka ◽  
Joanna Brągoszewska ◽  
Lidia Popek ◽  
...  

Objective. Omega–3 polyunsaturated fatty acids (PUFAs) were tested in adolescent depression and in several neurodevelopmental disorders with partial success. Anorexia nervosa (AN) is characterised by deficiencies in fatty food intake and frequent comorbidity, including depressive and cognitive symptoms. Thus supplementation with PUFAs may be beneficial in this group of patients. The aim of the study was to assess whether PUFAs as an add-on treatment is associated with better improvement of body mass index (BMI) and psychopathological symptoms than placebo in patients with AN. Method. 61 female adolescent inpatients with AN were randomly allocated to omega–3 PUFAs supplementation or placebo for 10 weeks. Patients also participated in the behavioural programme and eclectic psychotherapy (treatment as usual, TAU). At baseline and follow-up visits, patients’ BMI and psychopathology were assessed with Clinical Global Impression Scale (CGI), Patient Global Impression Scale (PGI), and Eating Attitude Test (EAT-26). Results. After 10 weeks, both groups showed improvement in all parameters. Improvement in CGI scores was observed greater in placebo vs. PUFA-s group (p = 0.015) while other differences were not statistically significant. Omega–3 PUFAs supplementation appears not to be effective as an add-on treatment in inpatient adolescent girls with anorexia nervosa. Conclusions. The results should be analysed with caution due to small sample size and heterogeneity in TAU. As the TAU turned out to be highly effective, additional therapeutic effect of PUFA might not be visible. Nevertheless, that does not explain the tendency for better improvement in the placebo group.


2013 ◽  
Author(s):  
Natalie Shepherd ◽  
Jager Cassandre De ◽  
Abe Kasonga ◽  
Sumari Marais ◽  
Yuko Tousen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document